Ibritumomab Pregnancy and Breast Feeding Warnings

Ibritumomab is also known as: In-111 Zevalin, Y-90 Zevalin, Zevalin

Overview

Ibritumomab Tiuxetan with Indium-111 has been shown to cause harm to the fetus. If you think that you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Ibritumomab Tiuxetan with Indium-111 while you are pregnant. It is not known if Ibritumomab Tiuxetan with Indium-111 is found in breast milk. Do not breast-feed while taking Ibritumomab Tiuxetan with Indium-111 .

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.